Kamile Cerlinskaite-Bajore🇱🇹🇺🇦🌻

MD, Cardiologist and researcher at Vilnius University, Lithuania. 🇱🇹 Interests: heart failure, echocardiography, imaging, data science and health equity.

[HFAPresident @HFA_President]

1️⃣
How to use GLP-1 RA in patients with #HeartFailure?

New #EJHF expert consensus document, a thread🧵:

📍Eligible pts: #HFpEF + #obesity (BMI ≥30 kg/m2)
📍Avoid/caution: #HFrEF, #worseningHF, #ESRD, prior pancreatitis, severe GI intolerance
📍Start low, titrate every 4 weeks
📍Side effects monitoring: fluid status, haemodynamics, GI tolerance, weight loss & nutritional status

More: https://t.co/DIMoVYHbmv

#HFA_ESC @escardio #semaglutide #tirzepatide #GLP1RA
@EJHFEiC @MarcoMetra @NicolasGirerd @LucaMonzo @GianluSava @WilfriedMullens @jozinetm @AmrAbdin10 @BiykemB @markcpetrie20 @RInciardi @HadidiSeif @gabrieleschiat1

[HFAPresident @HFA_President]

Multimodality imaging in advanced #HeartFailure (part 2):
#HFA_ESC Clinical Consensus Statement on #MCS & #HeartTransplantation 🫀

In #advancedHF care, #CVimaging is not just diagnostic, it is longitudinal surveillance across #LVAD and post-transplant care:
📍Candidate selection, ventricular+valve function, device positioning, unloading assessment, evaluation of #RV failure & device complications
📍Graft function, perfusion & rejection evaluation, CAV monitoring

More🔗: https://t.co/1sAWgmXKkl

@escardio @EJHFEiC @ESC_Journals
@MarcoMetra @jozinetm @AlbertoAimo90 @MajaCikes @FinnGustafsson @kevin_damman @juliendreyfus1

#EchoFirst #yesCCT #whyCMR #ThinkPET

[HFAPresident @HFA_President]

🔥New Scientific Statement from #HFA & #HFAI: SGLT2 inhibitors for the prevention & treatment of #HeartFailure

Key recommendations across the HF spectrum:
📍At risk for HF: ⬇️HF events in patients with #T2DM & #CKD, initiate #SGLT2i
📍Post-AMI: ⬇️HFh alone, consider in high-risk patients
📍Symptomatic chronic HF: ⬇️HFh & #CVdeath across LVEF, start early
📍Acute/worsening HF: early benefit on HF events & mild decongestion, initiate inpatient & have 💊 on board before discharge
📍Specific populations (#ATTRCM, #ACHD): observational data suggest safety & potential benefit

Read the full statement @ESCHeartFailure ➡️ https://t.co/PgjB6j6xyb

#HFA_ESC #CardioX @escardio @ESC_Journals @MarcoMetra @jozinetm @GMCRosano @GianluSava

[Muthu Vaduganathan @mvaduganathan]

A beautiful "explainer" of everything a cardiologist needs to know about #eGFR in HF clinical practice with modern #GDMT

...and a plug to bring back #eGFRslope as an endpoint in HF clinical trials

New in #EHJ with leading nephrologists @brendonneuen
https://t.co/VPkajZrztH

[Jozine ter Maaten @jozinetm]

The future of the #HFA is bright! ✨
@HFA_President @escardio @WilfriedMullens

[Cornelia Margineanu @corneliacrm]

Tomorrow morning, after the HFA Millionaire, the #HFAYoung Committee invites everyone to the annual group photo!

Please spread the word to your friends and colleagues — see you at the HFA stage! ❤️

#HeartFailure2025

@HFA_President @escardio

[Gregorio Tersalvi @GTersalvi]

💭“Be yourself”
“Don’t ask others to do things that you won’t do yourself”
“Lead by example, not by words”
“To be a team leader, you need a team. Select people that are enthusiastic and have human values”

Great advices from extraordinary mentors at #HFAStage!!

#HeartFailure2025

[Kamile Cerlinskaite-Bajore🇱🇹🇺🇦🌻 @cerlinskaite]

#HeartFailure2025 started with a bang!

Thank you #HFAYoung community for organizing the quiz and @jozinetm for hosting!

[Cornelia Margineanu @corneliacrm]

Amazing day already for @cerlinskaite - the first winner of the Who wants to be a millionaire?

#HFAcongress2025 #HFAMotions

@HFA_President @escardio @ab_barth_HFA @slumberbell @jozinetm @SotiriaLiori @RosalynnAustin @m4ggiesimpson @ARakisheva @ShelleyZieroth @JBauersachsMD

[NEJM @NEJM]

Presented at #ACC25:

Among older patients undergoing TAVI, dapagliflozin led to a lower incidence of a composite of death from any cause or worsening of heart failure than standard care at 1 year. Full DapaTAVI trial results: https://t.co/QgikchFPtJ

Editorial: Aortic Stenosis — When Valve Intervention Is Not Enough https://t.co/wLQEK04zwy

@ACCinTouch

[NEJM @NEJM]

#ACC24 Round Up: Ten Original Articles were simultaneously published in NEJM and presented at this year’s American College of Cardiology Scientific Sessions in Atlanta. View the full thread for all @ACCinTouch articles and bookmark this post for future reference.

[Gregg Fonarow MD @gcfmd]

HFrEF ↘️↘️↘️median survival 7-18 years

GDMT ↗️↗️↗️ median survival:

✅ ARNI 2-3 yrs (1-2 yrs vs ACEI or ARB)
✅ BB 3-4 yrs
✅ MRA 2-3 yrs
✅ SGLTi 1-2 yrs

Clinical benefits non-overlapping, incremental, additive

Quadruple >>>triple>>>double

Fast >>>>slow

Now>>>later

[Saad Ur Rahman @SaadUrRahman55]

Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch

1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart transplantation, HF hospitalizations, outpatient worsening HF events.

[Kamile Cerlinskaite-Bajore🇱🇹🇺🇦🌻 @cerlinskaite]

Features Late-Breaking Clinical Science session in #THT2024 with sim pub in @CircHF
Early ⬆️ of #GDMT significantly improved all dimensions of #QoL in AHF patients and prognosis regardless of baseline QoL.

@AlexMebazaa @JCelutkiene @crfheart @BurkhoffMd
#BethDavison #GadCotter

[Karl-Philipp Rommel @kp_rommel]

🚀 #StrongHF presentation by @cerlinskaite at #THT2024

⬆️ QoL across all categ. w/ high-intensity GDMT in #heartfailure ➕ consistent Tx effect across spectrum of baseline QoL

@crfheart @AlexMebazaa @guilbon @BurkhoffMd #BethDavison

Sim Pub @CircHF: https://t.co/PQh6gNeT9t

[Circ: Heart Failure @CircHF]

Sim Pub with #THT2024: Early up-titration of HF therapy improves all dimensions of quality of life, regardless of baseline quality of life.

Read more: https://t.co/JOsHBJzhtx #AHAJournals

@JCelutkiene @VU_LT @Filippatos @AdriaanVoors @jozinetm @JanBiegus

[Zurich Heart House (ZHH) @zhh_ch]

Welcome to Module 3 #PCHFLondon @zhh_ch @TomLuscher @ruthamstein @LarsKober We have a fantastic programme coming up! @BritishCardioSo @BSHeartFailure @escardio #CardioTwitter #CardioEd

[Julia Seller @JuliaSellerm]

Top3 heart failure trials in October 2023

🥇Recent successes in HF treatment @NatRevCardiol

🥈AHF: current pharmacological treatment and perspectives @ESC_Journals

��Administration of subcutaneous furosemide➡️ results of two phase I studies
@ESC_Journals

[Carolyn Lam @lamcardio]

Remarkable recent advances have revolutionized the field of heart failure…!
https://t.co/FRXhtolTvz

[Zurich Heart House (ZHH) @zhh_ch]

First day of the #PCHFLondon Module 2.
We are looking forward to an exciting programme. And we are wishing to all our participants a good start!
#heartfailure
#Cardiology
@TomLuscher
@zhh_ch

[Stephan Achenbach @Steph_Achenbach]

The visual summaries of all Hot Line trials at #ESCCongress 2023 are an extremely useful resource provided by @escardio.
Free access at https://t.co/kF9CVZVRyS

#CardioTwitter